One of the earliest attempts to classify DLBCL by IHC used markers of B-cell differentiation, including CD10 and BCL6 for GCB expression patterns and IRF4/MUM1 and CD138 expression patterns, but did not predict clinical outcome33. Here, IRF4 is linked to diffuse large B-cell lymphoma.